The Urology Residency Program of the Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Graduate Medical Education (ACGME). Our program is designed to train residents in all aspects of the medical and surgical evaluation and treatment of genitourinary disease.
Urology Residency Program
How to Apply
Our residency program recruits five trainees a year through the AUA Residency Match, which uses the AAMC’s ERAS application system. Three letters of reference are required. Registration for the Match begins in the summer. Applications are distributed to the programs designated by the applicants in mid-September.
Our Urology Residency is authorized by the ACGME to recruit five residents per year. Here is a list of our current residents.
Kyrollis Attalla, MD
Julio Chong, MD
Miriam Greenstein, MD
Ted Vellos, MD
Jared Winoker, MD
David Ahlborn, MD
Zeynep Gul, MD
Marissa Kent, MD
Jason Rothwax, MD
Peter Sunyaro, MD
Eric Bortnick, MD
Christine Liaw, MD
Daniel Rosen, MD
Rollin Say, MD
Conner Brown, MD
Andrew Katims, MD
Gregory Mullen, MD
Andrew Tam, MD
Harry Anastos, MD
Shivaram Cumarasamy, MD
Beth Edelblute, MD
Shirin Razdan, MD
Our recent graduates have matched into the most competitive fellowships and have secured prestigious academic and private practice positions. Here is a list of our recent graduates.
Jaime A. Cavallo, MD
Lahey Hospital and Medical Center – Male Genitourinary Reconstructive Urologic Surgery Fellowship
John Griffith, MD
Hartford Healthcare Medical Group – Private Practice in Manchester, CT
Matthew L. Goland-Van Ryn, MD
Yale School of Medicine – Endourology Fellowship
Milan Shah, MD
Loma Linda University Medical Center – Endourology Fellowship
David Wu Shi, MD
Merrimack Urology Associates, PC – Private Practice in Boston, MA
The creation of the Mount Sinai Health System provides our residents with the resources of the largest network of hospitals in New York. Our residents benefit from the instruction and supervision of both full-time and voluntary faculty in the Mount Sinai Health System and at our affiliated institutions.
The Mount Sinai Urology Residency Program is focused at The Mount Sinai Hospital, with rotations at Mount Sinai St. Luke’s, Mount Sinai Beth Israel, Mount Sinai West, Elmhurst Hospital Center, and Queens Hospital Center.
The Mount Sinai Hospital
In addition to the ten full-time clinical faculty in urology, there are 24 voluntary faculty who practice urology at The Mount Sinai Hospital and a research staff overseen by four faculty PhDs. As a result, residents have a broad exposure to every aspect of urology during their rotations, including oncology, stone disease, female urology, pediatric urology, neuro-urology, impotence and infertility, prostatic diseases, and state-of-the-art endo-urologic and laparoscopic procedures as well as laboratory and demographic research methods.
Mount Sinai St. Luke’s and Mount Sinai West
Mount Sinai St. Luke’s and Mount Sinai West have functioned as a single institution for a number of years, with a unified Department of Urology providing all of the urologic care at both sites. The rotations at Mount Sinai St. Luke’s and Mount Sinai West provide residents with a concentrated experience in endourology and stone disease and with expanded access to robotic and other laparoscopic oncology cases.
Mount Sinai Beth Israel
Michael Palese, MD, the site Chair and a faculty of six full-time and numerous voluntary urologists currently provide the instruction for the Mount Sinai Beth Israel Residency.
The Elmhurst Hospital Center
Elmhurst Hospital Center offers residents experience in treating a variety of urological diseases and conditions, including trauma, as well as the opportunity to interact with patients who have come to from around the world.
Queens Hospital Center
Like Elmhurst, Queens Hospital Center is part of New York City Health and Hospitals Corporation’s Queens Health Network. The residents are exposed to general urology under the guidance of Hugh Lavery, MD, and a part-time attending staff, while they care for the institution’s oncology patients under the supervision of Dr. Isuru Jayaratna, MD, a fellowship-trained oncologist on the full-time staff of The Mount Sinai Hospital.